Procedures & Treatments
| On May 12, 2020, Minerva Surgical, Inc, acquired the following Intrauterine Health products from Boston Scientific: the Symphion™ Tissue Removal System; the Resectr™ Tissue Resection Device; and the Genesys HTA™ System. For more information, please visit Minerva Surgical or email meetminerva@minervasurgical.com. |
Endometrial Ablation
Endometrial ablation is a procedure often used to treat menorrhagia. By ablating or destroying a thin layer of the endometrium (e.g., uterine lining), menstrual flow may be stopped or reduced significantly.1
Genesys HTA™ System
On May 12, 2020, Minerva Surgical, Inc, acquired the following Intrauterine Health products from Boston Scientific: the Symphion™ Tissue Removal System; the Resectr™ Tissue Resection Device; and the Genesys HTA™ System. For more information, please visit Minerva Surgical or email meetminerva@minervasurgical.com. |
A proven therapy intended to treat menorrhagia, the Genesys HTA™ System has the highest amenorrhea rates1 and is the only device to allow continuous visualization throughout the procedure. Seeing is believing.
Hysteroscopic Tissue Removal
Hysteroscopic tissue removal, also known as myomectomy or polypectomy, is a minimally invasive option to remove abnormal uterine growths, such as fibroids and polyps. As a minimally invasive technique, no incisions are needed and recovery is typically short.
Symphion™ Tissue Removal System
On May 12, 2020, Minerva Surgical, Inc, acquired the following Intrauterine Health products from Boston Scientific: the Symphion™ Tissue Removal System; the Resectr™ Tissue Resection Device; and the Genesys HTA™ System. For more information, please visit Minerva Surgical or email meetminerva@minervasurgical.com. |
The all-in-one Symphion System is designed to transform the way you remove uterine tissue. It unites breakthrough fluid management, direct intrauterine pressure monitoring and bladeless resection to work together in perfect harmony. So you can stay focused on what matters most – your patients.
Resectr™ Tissue Resection Device
On May 12, 2020, Minerva Surgical, Inc, acquired the following Intrauterine Health products from Boston Scientific: the Symphion™ Tissue Removal System; the Resectr™ Tissue Resection Device; and the Genesys HTA™ System. For more information, please visit Minerva Surgical or email meetminerva@minervasurgical.com. |
Compatible with your existing gynecologic surgery instrumentation, Resectr is a versatile and cost-effective polypectomy tool for a variety of surgical settings. See how Resectr gives you control without added complexity or costs.